Call for Abstract

13th Annual congress on Vaccines, Therapeutics & Travel Medicine : Influenza and Infectious diseases, will be organized around the theme “Research and Methodology Implemented on Influenza Vaccines & Respiratory diseases”

IRDI Vaccines 2016 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in IRDI Vaccines 2016

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

The word “vaccine” originates from the Latin Variolae vaccinae (cowpox), which Edward Jenner demonstrated in 1798 could prevent smallpox in humans.  Today the term ‘vaccine’ applies to all biological preparations, produced from living organisms, that enhance immunity against disease and either prevent (prophylactic vaccines) or, in some cases, treat disease (therapeutic vaccines). Vaccines research and development are administered in liquid form, either by injection,  by oral,  or by intranasal routes.  Vaccination is the administration of antigenic material (a vaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen.  Vaccination is the administration of antigenic material to stimulate an individual's immune system to develop adaptive immunotherapeutic to pathogen.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions. 

  • Track 1-1Vaccine Efficacy and Safety
  • Track 1-2Vaccine Safety Surveillance and Evaluation
  • Track 1-3Cost-Effectiveness Analyses and Evaluation
  • Track 1-4Vaccine Implementation Options
  • Track 1-5Warnings and Precautions
  • Track 1-6Preparation of the Vaccine Strain
  • Track 1-7Vaccine Bulk Manufacture
  • Track 1-8Survey of Vaccine-Preventable Diseases

Immunology is the branch of biomedical sciences concerned with all aspects of the immunological research in all multicellular organisms. Antiviral resistance in influenza may not only develop during treatment but also sometimes transmit widely to replace susceptible strains in the absence of drug pressure. Although instances of antiviral drug resistance among influenza viruses have occurred during antiviral therapy, resistant influenza strains have spread widely in the absence of such drug pressure. Influenza occurs in outbreaks and epidemics worldwide, mainly during the winter season. Although acutely debilitating, influenza is usually a self-limited infection; however, it is associated with increased morbidity and mortality in certain high-risk populations.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

  • Track 2-1The Biology of H1N1- Genome Structure
  • Track 2-2Influenza Virus and Strains
  • Track 2-3Influenza Antigenic Changes- A (H1N1) Immune Escape Mutants
  • Track 2-4Immuno Response
  • Track 2-5Antiviral Resistance
  • Track 2-6Evolution and Genetic Diversity

H1N1 Flu is also known as swine flu. It's called swine flu because in the past, the people who caught it had direct contact with pigs. That changed several years ago, when a new virus emerged that spread among people who hadn't been near pigs. In 2009, H1N1 was spreading fast around the world, so the World Health Organization called it a pandemic. Since then, people have continued to get sick from swine flu, but not as many. H1n1 diagnosis is recommended on suspect cases of novel influenza A H1N1 (swine flu). Active infection with swine flu diagnosis influenza can only be confirmed by polymerase chain reaction (PCR) assays, including sub-typing and further characterization by other special PCR assays. H1N1 flu virus is contagious. Person-to-person transmission of H1N1 flu virus occurs, and the virus is easily spread among people. It is believed that it is spread the same way as regular seasonal influenza. A person infected with H1N1 flu virus can infect others starting 1 day before symptoms develop and up to 7 or more days after becoming ill.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions. 

  • Track 3-1Assessing Influenza Virus Deposition and Survival in the Environment
  • Track 3-2Genetic Variations
  • Track 3-3Outbreak Investigations
  • Track 3-4Prospective Intervention Studies in the Setting of Natural Infection
  • Track 3-5Molecular Diagnostics
  • Track 3-6Virus Isolation and Typing using Haemagglutination Inhibition or Immunofluorescence
  • Track 3-7Rapid Tests or Immunofluorescence
  • Track 3-8Reverse Transcription PCR

Influenza occurs in distinct outbreaks of varying extent every year. The influenza epidemiology pattern reflects the changing nature of the antigenic properties of influenza viruses, and their subsequent spread depends upon multiple factors, including transmissibility of the virus and the susceptibility of the population. Influenza A viruses, in particular, has a remarkable ability to undergo periodic changes in the antigenic characteristics of their envelope glycoproteins, the hemagglutinin and the neuraminidase. Influenza is a highly infectious disease which can occur as a pandemic, epidemic, outbreak and in form of sporadic cases. While in home isolation, patients and other household members should be given infection control instructions, including frequent hand washing with soap and water. Use alcohol-based hand gels (containing at least 60% alcohol) when soap and water are not available and hands are not visibly dirty. Patients with H1N1 influenza should wear a face mask when within 6 feet of others at home.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.  

  • Track 4-1Rapid Containment of Pandemic Influenza: Strategy and Protocol
  • Track 4-2Global Outbreak and Alert Response Network: A(H1N1) Initial Alert and Response
  • Track 4-3Country Operation Support and logistics Coordination: Antiviral Stockpile Deployment
  • Track 4-4EMS (Event Management System)
  • Track 4-5Monitoring and Tracking Global and Regional Progression, Transmission, and Impact of the Pandemic
  • Track 4-6Generating and Sharing Authoritative Information to Support Country Interventions and Mitigation Strategies

Influenza treatment and therapies are largely supportive and consists of bed rest, increased fluid consumption, cough suppressants, and antipyretics and analgesics. Patients should be encouraged to stay home if they become ill, to avoid close contact with people who are sick, to wash their hands often, and to avoid touching their eyes, nose, and mouth. Patients who develop flu like illness (i. e, fever with either cough or sore throat) should be strongly encouraged to self-isolate in their home for 7 days after the onset of illness or at least 24 hours after symptoms have resolved, whichever is longer. To seek medical care, patients should contact their health care providers to report illness (by telephone or other remote means) before seeking care at a clinic, physician's office, or hospital.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions. 

  • Track 5-1Antiviral Therapy
  • Track 5-2Considerations
  • Track 5-3Complications
  • Track 5-4Comorbidity-Problems
  • Track 5-5Others

H1N1 influenza is sometimes called "swine flu" because it is usually found in pigs. You cannot become infected with H1N1 influenza from eating pork products. H1N1 influenza virus can spread from one person to another through small droplets of saliva that are expelled into the air when an infected person coughs or sneezes. The virus can also be passed through contact with objects the infected person has touched, such as a door handle or other surfaces. Becoming infected with influenza is much more dangerous to your health than receiving the vaccine to protect against it. Most people with H1N1 influenza have recovered, but the virus has caused some deaths. Like any medicine, this vaccine can cause side effects, but the risk of serious side effects is extremely low.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions. 

  • Track 6-1Indication and Usage – Dosage and Administration
  • Track 6-2Dosage Forms, Strengths and Contraindications
  • Track 6-3Adverse Reactions and Drug Interactions
  • Track 6-4Use in Specific Populations- Description
  • Track 6-5Clinical Pharmacology and Nonclinical Toxicology
  • Track 6-6Clinical Studies

Influenza can induce serious Acute respiratory distress syndrome (ARDS) and non-conventional treatment like extracorporeal membrane oxygenation (ECMO), can be safely instituted in highly specialized centres. Due to a rapid progression of respiratory failure, transfer of these patients to a referral centre on mechanical ventilation is often infeasible. Therefore the start of ECMO flu treatment and care at the peripheral hospitals and transportation on ECMO could be a viable option. The creation of an ECMO team, with experts in the treatment of ARDS, seems a key aspect for the safe management of these patients, including when the most advanced technique are not immediately available.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.  

  • Track 7-1New Protective Vaccines
  • Track 7-2Vaccines Effective against Newly Emerging Influenza Viruses
  • Track 7-3Adjuvant Development, from Early Discovery to Clinical Evaluation
  • Track 7-4Safety and Efficacy in Special Populations

The H1N1 Influenza A (2009) pandemic has affected more than 0. 4 million people in 180 countries across the globe. The alphabets H and N designate the proteins Hemagglutinin and Neuraminidase present on the surface area of the virus. The flu first began in Mexico in March 2009, then affected the U. S., after which it spread across the globe. The H1N1/09 virus has genetic elements originating from avian, swine, and human sources, making it far more fatal than the 1918 H1N1 (Spanish Flu) outbreak. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The H1N1 Vaccines market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analysed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions. 

  • Track 8-1Surveillance
  • Track 8-2Verification of the Vaccine Strain
  • Track 8-3Preparation of Reagents to Test the Vaccine (with reference reagents)
  • Track 8-4Optimization of Virus Growth Conditions
  • Track 8-5Vaccine Bulk Manufacture
  • Track 8-6Quality Control
  • Track 8-7Vaccine Filling and Release
  • Track 8-8Recent Techniques and Innovation

Although the timing and severity of the next influenza pandemic is impossible to predict, there is broad agreement that one will occur. Preparation is vital to mitigating its effects. A severe influenza pandemic like that which began in 1918 would be unlike other disasters in nature, scale, and duration. It could cripple normal business operations and disrupt global distribution of essential goods and services. Public health officials around the world are developing plans for handling an influenza pandemic in response to experts’ warnings that a widespread outbreak of the respiratory virus is inevitable. A pandemic occurs when a new strain of virus—one to which humans have not developed autoimmunity-becomes highly contagious and spreads across continents. But knowing when such an outbreak might happen is impossible to predict. In a severe pandemic flu, veterans’ health association (VHA), like other health care organizations, will face a surge in demand for care to large numbers of very sick people in the context of a highly transmissible disease.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions

  • Track 9-1Equitable Access to Therapeutic and Prophylactic Measures
  • Track 9-2Isolation, Quarantine, Border Control and Social-Distancing Measure
  • Track 9-3The Role and Obligations of Health-Care Workers during an Outbreak of Pandemic Influenza
  • Track 9-4Pandemic Influenza Planning and Response – Transnational Issues for Governments

Healthy and at risk children are susceptible to the morbidity and mortality associated with viral-induced respiratory diseases, including respiratory syncytial virus (RSV) and influenza. The World Health Organization is attempting to develop and distribute effective vaccines to prevent/reduce key viral respiratory diseases. Effective vaccines are available for some viral respiratory pathogens (eg: influenza or virus), but not for most mucosal restricted respiratory viral pathogens. Research should continue into safe and effective vaccine for all childhood viral illnesses.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

  • Track 10-1viral-induced respiratory diseases
  • Track 10-2viral respiratory infections
  • Track 10-3viral respiratory pathogens
  • Track 10-4Various RSV vaccine formulations
  • Track 10-5Immunological disorders

Respiratory Tract Infections (RTIs) can spread in several ways. If you have an infection such as a cold, tiny droplets of fluid containing the cold virus are launched into the air whenever you sneeze or cough. If these are breathed in by someone else, they may also become infected. Infections can also be spread through indirect contact. For example, if you have a cold and you touch your nose or eyes before touching an object or surface, the virus may be passed to someone else when they touch that object or surface. The best way to prevent spreading infections is to practise good hygiene, such as regularly washing your hands with soap and warm water.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions. 

  • Track 11-1Nasopharyngeal cold
  • Track 11-2Lung Diseases
  • Track 11-3Pharyngitis
  • Track 11-4Epiglottis
  • Track 11-5Otitis

Infectious diseases also known as contagious diseases, transmissible diseases or communicable diseases are caused by pathogenic microorganisms that infect a host organism and can be spread, directly or indirectly, from one organism to another. Diseases caused by the invasion of a pathogen, including bacteria, viruses, fungi and parasites.  These are typically contagious diseases and include: AIDS/HIV, influenza, common cold, vaccine, sexually transmitted diseases, gastroenteritis, etc.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions. 

  • Track 12-1Cervical Dysplasia
  • Track 12-2Allergy
  • Track 12-3AIDS/HIV
  • Track 12-4Aspergillosis
  • Track 12-5Gynaecological Infections

Respiratory disease is a medical term that encompasses pathological conditions affecting the organs and tissues that make gas exchange possible in higher organisms, and includes conditions of the upper respiratory tract, trachea, bronchi, bronchioles, alveoli, pleura and pleural cavity, and the nerves and muscles of breathing. Respiratory diseases range from mild and self-limiting, such as the common cold, to life-threatening entities like bacterial pneumonia, pulmonary embolism, and lung cancer. A respiratory disease prevents disease, disability, and death through immunological abnormalities and by control of respiratory and related diseases.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions. 

  • Track 13-1Bronchial Asthma
  • Track 13-2Chronic Obstructive Pulmonary Disease
  • Track 13-3Pnemonia
  • Track 13-4Chronic Bronchitis
  • Track 13-5Emphysema

Vaccines also may contain very small amounts of the culture material used to grow the virus or bacteria used in the vaccine, such as chicken egg protein. Scientists have long figured it should be possible to rev up the immune system on command, to give the body's own natural defences an extra surge of power to attack tumour’s and fight diseases. But decades of working on the challenge have seen many promising clinical trials of potential "immune modulators," "immune stimulators" and "therapeutic vaccines" end in disappointment.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions. 

  • Track 14-1Anti-microbial Resistance
  • Track 14-2Emerging Infectious Diseases
  • Track 14-3Antimicrobials and Latest Innovations
  • Track 14-4Immunological Resistance
  • Track 14-5Immune modulators

The Indian economy is among the fastest growing economies in the world.  The country forayed into manufacturing vaccines starting with a few public-sector manufacturers in the late 1960s but has emerged as the major supplier of basic Expanded Programme on Immunization vaccines to the United Nations.  In addition to the need for vaccines and ancillary products,  there was also a clear need for funding to support the costs of safely deploying vaccines to countries,  and for safely distributing and administering them within the systems of recipient countries once they arrived.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions. 

 

  • Track 15-1Improving pandemic vaccine deployment
  • Track 15-2Collaborations
  • Track 15-3Business Development
  • Track 15-4Investment and Development
  • Track 15-5Flu Vaccines: Expect More Modern
  • Track 15-6Effective Versions-About to hit market
  • Track 15-7Accelerating vaccine development
  • Track 15-8Regulatory reform